Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
The global Antibody Services market size was valued at US$ 2276 million in 2023 and is forecast to a readjusted size of USD 4182 million by 2030 with a CAGR of 9.2% during review period.
Thermo Fisher ranks the first in terms of revenue share in global market of Antibody Services, occupies 18% of the global market share. While, Covance, with a market share of 14%, comes the second. All the other manufacturers which are not included in the report together consist of approximately 46% of the global market.
North America ranks the top in terms of market size of Antibody Services, which alone consists of 40% of the global market. Europe comes the second, with 31% of the global market. Asia Pacific ranks the third, consists of about 18% of the global antibody service market in the same year. All the other regions combined occupy only 8% of the global Antibody Service market.
This report is a detailed and comprehensive analysis for global Antibody Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Antibody Services market size and forecasts, in consumption value ($ Million), 2019-2030
Global Antibody Services market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Antibody Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Antibody Services market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ThermoFisher, GenScript, Abcam, MBS, ROCKLAND, ProSci, Anaspec, Bio-Rad, Covance, Capra Science, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Âé¶¹Ô´´ segmentation
Antibody Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Âé¶¹Ô´´ segmentation
Antibody Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Âé¶¹Ô´´ segment by Type
Monoclonal
Polyclonal
Others
Âé¶¹Ô´´ segment by Application
BioScience Companies
BioScience Research Institutions
Hospitals
Other
Âé¶¹Ô´´ segment by players, this report covers
ThermoFisher
GenScript
Abcam
MBS
ROCKLAND
ProSci
Anaspec
Bio-Rad
Covance
Capra Science
Innovagen
APS
Randox
GL Biochem
Abgent
Âé¶¹Ô´´ segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antibody Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Services, with revenue, gross margin, and global market share of Antibody Services from 2019 to 2024.
Chapter 3, the Antibody Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antibody Services market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Services.
Chapter 13, to describe Antibody Services research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope
1.2 Âé¶¹Ô´´ Estimation Caveats and Base Year
1.3 Classification of Antibody Services by Type
1.3.1 Overview: Global Antibody Services Âé¶¹Ô´´ Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Antibody Services Consumption Value Âé¶¹Ô´´ Share by Type in 2023
1.3.3 Monoclonal
1.3.4 Polyclonal
1.3.5 Others
1.4 Global Antibody Services Âé¶¹Ô´´ by Application
1.4.1 Overview: Global Antibody Services Âé¶¹Ô´´ Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 BioScience Companies
1.4.3 BioScience Research Institutions
1.4.4 Hospitals
1.4.5 Other
1.5 Global Antibody Services Âé¶¹Ô´´ Size & Forecast
1.6 Global Antibody Services Âé¶¹Ô´´ Size and Forecast by Region
1.6.1 Global Antibody Services Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Antibody Services Âé¶¹Ô´´ Size by Region, (2019-2030)
1.6.3 North America Antibody Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.4 Europe Antibody Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Antibody Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.6 South America Antibody Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Antibody Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
2 Company Profiles
2.1 ThermoFisher
2.1.1 ThermoFisher Details
2.1.2 ThermoFisher Major Business
2.1.3 ThermoFisher Antibody Services Product and Solutions
2.1.4 ThermoFisher Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.1.5 ThermoFisher Recent Developments and Future Plans
2.2 GenScript
2.2.1 GenScript Details
2.2.2 GenScript Major Business
2.2.3 GenScript Antibody Services Product and Solutions
2.2.4 GenScript Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.2.5 GenScript Recent Developments and Future Plans
2.3 Abcam
2.3.1 Abcam Details
2.3.2 Abcam Major Business
2.3.3 Abcam Antibody Services Product and Solutions
2.3.4 Abcam Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.3.5 Abcam Recent Developments and Future Plans
2.4 MBS
2.4.1 MBS Details
2.4.2 MBS Major Business
2.4.3 MBS Antibody Services Product and Solutions
2.4.4 MBS Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.4.5 MBS Recent Developments and Future Plans
2.5 ROCKLAND
2.5.1 ROCKLAND Details
2.5.2 ROCKLAND Major Business
2.5.3 ROCKLAND Antibody Services Product and Solutions
2.5.4 ROCKLAND Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.5.5 ROCKLAND Recent Developments and Future Plans
2.6 ProSci
2.6.1 ProSci Details
2.6.2 ProSci Major Business
2.6.3 ProSci Antibody Services Product and Solutions
2.6.4 ProSci Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.6.5 ProSci Recent Developments and Future Plans
2.7 Anaspec
2.7.1 Anaspec Details
2.7.2 Anaspec Major Business
2.7.3 Anaspec Antibody Services Product and Solutions
2.7.4 Anaspec Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.7.5 Anaspec Recent Developments and Future Plans
2.8 Bio-Rad
2.8.1 Bio-Rad Details
2.8.2 Bio-Rad Major Business
2.8.3 Bio-Rad Antibody Services Product and Solutions
2.8.4 Bio-Rad Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.8.5 Bio-Rad Recent Developments and Future Plans
2.9 Covance
2.9.1 Covance Details
2.9.2 Covance Major Business
2.9.3 Covance Antibody Services Product and Solutions
2.9.4 Covance Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.9.5 Covance Recent Developments and Future Plans
2.10 Capra Science
2.10.1 Capra Science Details
2.10.2 Capra Science Major Business
2.10.3 Capra Science Antibody Services Product and Solutions
2.10.4 Capra Science Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.10.5 Capra Science Recent Developments and Future Plans
2.11 Innovagen
2.11.1 Innovagen Details
2.11.2 Innovagen Major Business
2.11.3 Innovagen Antibody Services Product and Solutions
2.11.4 Innovagen Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.11.5 Innovagen Recent Developments and Future Plans
2.12 APS
2.12.1 APS Details
2.12.2 APS Major Business
2.12.3 APS Antibody Services Product and Solutions
2.12.4 APS Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.12.5 APS Recent Developments and Future Plans
2.13 Randox
2.13.1 Randox Details
2.13.2 Randox Major Business
2.13.3 Randox Antibody Services Product and Solutions
2.13.4 Randox Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.13.5 Randox Recent Developments and Future Plans
2.14 GL Biochem
2.14.1 GL Biochem Details
2.14.2 GL Biochem Major Business
2.14.3 GL Biochem Antibody Services Product and Solutions
2.14.4 GL Biochem Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.14.5 GL Biochem Recent Developments and Future Plans
2.15 Abgent
2.15.1 Abgent Details
2.15.2 Abgent Major Business
2.15.3 Abgent Antibody Services Product and Solutions
2.15.4 Abgent Antibody Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.15.5 Abgent Recent Developments and Future Plans
3 Âé¶¹Ô´´ Competition, by Players
3.1 Global Antibody Services Revenue and Share by Players (2019-2024)
3.2 Âé¶¹Ô´´ Share Analysis (2023)
3.2.1 Âé¶¹Ô´´ Share of Antibody Services by Company Revenue
3.2.2 Top 3 Antibody Services Players Âé¶¹Ô´´ Share in 2023
3.2.3 Top 6 Antibody Services Players Âé¶¹Ô´´ Share in 2023
3.3 Antibody Services Âé¶¹Ô´´: Overall Company Footprint Analysis
3.3.1 Antibody Services Âé¶¹Ô´´: Region Footprint
3.3.2 Antibody Services Âé¶¹Ô´´: Company Product Type Footprint
3.3.3 Antibody Services Âé¶¹Ô´´: Company Product Application Footprint
3.4 New Âé¶¹Ô´´ Entrants and Barriers to Âé¶¹Ô´´ Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Âé¶¹Ô´´ Size Segment by Type
4.1 Global Antibody Services Consumption Value and Âé¶¹Ô´´ Share by Type (2019-2024)
4.2 Global Antibody Services Âé¶¹Ô´´ Forecast by Type (2025-2030)
5 Âé¶¹Ô´´ Size Segment by Application
5.1 Global Antibody Services Consumption Value Âé¶¹Ô´´ Share by Application (2019-2024)
5.2 Global Antibody Services Âé¶¹Ô´´ Forecast by Application (2025-2030)
6 North America
6.1 North America Antibody Services Consumption Value by Type (2019-2030)
6.2 North America Antibody Services Âé¶¹Ô´´ Size by Application (2019-2030)
6.3 North America Antibody Services Âé¶¹Ô´´ Size by Country
6.3.1 North America Antibody Services Consumption Value by Country (2019-2030)
6.3.2 United States Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
6.3.3 Canada Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
6.3.4 Mexico Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7 Europe
7.1 Europe Antibody Services Consumption Value by Type (2019-2030)
7.2 Europe Antibody Services Consumption Value by Application (2019-2030)
7.3 Europe Antibody Services Âé¶¹Ô´´ Size by Country
7.3.1 Europe Antibody Services Consumption Value by Country (2019-2030)
7.3.2 Germany Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.3 France Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.4 United Kingdom Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.5 Russia Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.6 Italy Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Antibody Services Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Antibody Services Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Antibody Services Âé¶¹Ô´´ Size by Region
8.3.1 Asia-Pacific Antibody Services Consumption Value by Region (2019-2030)
8.3.2 China Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.3 Japan Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.4 South Korea Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.5 India Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.6 Southeast Asia Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.7 Australia Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
9 South America
9.1 South America Antibody Services Consumption Value by Type (2019-2030)
9.2 South America Antibody Services Consumption Value by Application (2019-2030)
9.3 South America Antibody Services Âé¶¹Ô´´ Size by Country
9.3.1 South America Antibody Services Consumption Value by Country (2019-2030)
9.3.2 Brazil Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
9.3.3 Argentina Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Antibody Services Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Antibody Services Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Antibody Services Âé¶¹Ô´´ Size by Country
10.3.1 Middle East & Africa Antibody Services Consumption Value by Country (2019-2030)
10.3.2 Turkey Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
10.3.4 UAE Antibody Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
11 Âé¶¹Ô´´ Dynamics
11.1 Antibody Services Âé¶¹Ô´´ Drivers
11.2 Antibody Services Âé¶¹Ô´´ Restraints
11.3 Antibody Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Antibody Services Industry Chain
12.2 Antibody Services Upstream Analysis
12.3 Antibody Services Midstream Analysis
12.4 Antibody Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
ThermoFisher
GenScript
Abcam
MBS
ROCKLAND
ProSci
Anaspec
Bio-Rad
Covance
Capra Science
Innovagen
APS
Randox
GL Biochem
Abgent
Ìý
Ìý
*If Applicable.